MOH Stock Analysis — Molina Healthcare
Sector: Healthcare
AI Verdict
Molina trades at 36.8x next year's earnings while analysts expect 53.8% EPS growth, so you're paying up for a Medicaid contract recovery narrative that hasn't materialized in the numbers yet—high expectations make this fragile if execution slips.
Competitive Moat
Molina Healthcare operates Medicaid and Medicare managed care plans for low-income populations, leveraging deep regulatory expertise and government relationships to win and retain state contracts. Its scale in Medicaid administration and ability to manage complex compliance requirements create high barriers for new entrants.
Summary
Molina's stock is notable for its sharp -34.98% one-year drop despite analyst expectations for a 53.8% jump in earnings next year.
Where It Stands
With a 56.0 RSI, MOH is trading in a neutral range after a -34.98% one-year return and now trades at 36.8x forward earnings, well above the healthcare sector median of 22x.
Key Metrics
- RSI: 56 — Neutral
- Trailing P/E: 56.6x
- Forward P/E: 36.8x
- PEG Ratio: 1.02
- Earnings Growth: +0.5%
- Revenue Growth: +0.1%
- Market Cap: $9.9B
- 1-Year Return: -34.98%
- 52-Week High: $311.52
- 52-Week Low: $121.06
Analyst Consensus
7 Buy · 16 Hold · 1 Sell (24 analysts)
Bull Case
Analysts expect 53.8% forward EPS growth, which if realized would make the current 36.8x forward P/E more reasonable for a company with entrenched Medicaid contracts.
Bear Case
If the forward P/E compresses from 36.8x to the sector median of 22x, the stock could see a further 40% downside even if earnings meet expectations.
Catalyst to Watch
Watch for upcoming state contract awards or renewals—winning or losing a major Medicaid contract will directly impact earnings visibility and sentiment.